These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

880 related items for PubMed ID: 17352309

  • 1. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY, Hsieh KS, Chiou YH, Chang YH, Ger LP.
    Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
    [Abstract] [Full Text] [Related]

  • 2. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E, Aslan Y, Gedik Y, Orhan F.
    Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS.
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [Abstract] [Full Text] [Related]

  • 4. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
    Gereige RS, Barrios NJ.
    P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
    [Abstract] [Full Text] [Related]

  • 5. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.
    Fujisawa K, Iyori H, Ohkawa H, Konishi S, Bessho F, Shirahata A, Miyazaki S, Akatsuka J, Japanese Study Group on Childhood ITP.
    Int J Hematol; 2000 Oct; 72(3):376-83. PubMed ID: 11185998
    [Abstract] [Full Text] [Related]

  • 6. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M, Vik TA, Johnson CS, Southwood ME, Croop JM.
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [Abstract] [Full Text] [Related]

  • 7. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
    Tamminga R, Berchtold W, Bruin M, Buchanan GR, Kühne T.
    Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A, Kovaleva L, Loria S, Alberca I, Hernandez F, Sandoval V, Sierra J, Vidaller A, Ayguasanosa J, Carretero M.
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of immune thrombocytopenic purpura in Pediatrics. Therapeutic efficacy of a regional intravenous immunoglobulin G].
    Buteler C, Colombo H, Gabosi G, Manfredi MJ, Montero S, Pasquali MA, Rougier C, Sisti AM.
    Medicina (B Aires); 2001 Oct; 61(5 Pt 1):522-8. PubMed ID: 11721317
    [Abstract] [Full Text] [Related]

  • 15. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
    Papagianni A, Economou M, Tragiannidis A, Karatza E, Tsatra I, Gombakis N, Athanassiadou-Piperopoulou F, Athanasiou-Metaxa M.
    J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials.
    Qin YH, Zhou TB, Su LN, Lei FY, Zhao YJ, Huang WF.
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):713-21. PubMed ID: 20962624
    [Abstract] [Full Text] [Related]

  • 18. Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: a multi-center randomized controlled trial.
    Treepongkaruna S, Sirachainan N, Kanjanapongkul S, Winaichatsak A, Sirithorn S, Sumritsopak R, Chuansumrit A.
    Pediatr Blood Cancer; 2009 Jul; 53(1):72-7. PubMed ID: 19301380
    [Abstract] [Full Text] [Related]

  • 19. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).
    O'Brien SH, Ritchey AK, Smith KJ.
    Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529
    [Abstract] [Full Text] [Related]

  • 20. [Randomized comparison of intravenous immunoglobulin and methylprednisolone pulse therapy in children with newly diagnosed idiopathic thrombocytic purpura. The Danish ITP Study Group].
    Rosthøj S, Nielsen SM, Pedersen FK.
    Ugeskr Laeger; 1998 Mar 09; 160(11):1640-4. PubMed ID: 9522658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.